Table 3.
Function | Microorganism | Type of Cancer | Mechanism | References |
---|---|---|---|---|
Cancer Therapy | Mycobacterium bovis BCG | Bladder | Stimulating the immune system and increasing the proinflammatory cytokines activation of cancer cells phagocytosis | [154,155,156,157,158] |
Streptococcus pyogenes OK-432 | Lymphangioma Intraoral Ranula | Immune activation by increasing cytokine levels | [159,160,161,162] | |
Clostridium novyi | Leiomyoma | Targeting and destroying tumor cells | [154,163,164,165] | |
Salmonella Typhimurium VNP20009 | Melanoma, Pancreatic | Helping antitumor drugs target cancer | [166,167] | |
Magnetococcus marinus | - | Targeted transport vector | [168,169] | |
Bifidobacterium Longum | Colorectal | Enhancing the body’s immune function and regulating the expression of tumor-related genes and cytokines | [170,171,172,173,174] | |
Listeria Monocytogenes LADD strain |
Cervical, Oropharyngeal, Pancreatic, Lung and Mesothelioma | Targeted transport vector | [175,176,177] | |
Escherichia Coli | - | Targeted transport vector | [178,179] | |
Tumor Promoters |
Gram-Negative Bacteria | Liver Colorectal |
TLR2 and TLR4 mediated upregulation of Innate inflammation; Induction of IL-17/23 pathway cytokines | [180,181,182] |
Helicobacter Pylori | Gastric | Inducing inflammation | [149,183,184] | |
Clostridium species | HCC | Production of deoxycholic acid from bile and inducing inflammation | [185] | |
Enterotoxigenic Bacteroides Fragilis |
Colon | Inducing inflammation | [186] | |
Fusobacterium | Colorectal | Inducing inflammation and protecting tumors from an immune cell attack | [187,188,189] | |
Escherichia Coli | Colorectal | PKS inducing DNA breaks | [190] | |
Chlamydia Pneumoniae | Lung | C. pneumoniae protein interfering with host cell behavior | [191] | |
Chlamydia Trachomatis | Cervical, Ovarian |
Promotes host cell DNA double-strand breaks, induces host cell genome instability and even transformation | [192] |